Insider · CIK 0001242110
Lawrence Blatt
Files at ALGS (Aligos Therapeutics, Inc.). First filing -, latest -.
In brief
Lawrence Blatt files SEC Form 4 as CEO, president and director at ALGS (Aligos Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lawrence Blatt has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | ALGS Aligos Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +105,840 | $0.00 | $0 | 105,840 | Mar 11, 2026 |
| Jul 16, 2025 | ALGS Aligos Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +179,800 | $0.00 | $0 | 179,800 | Jul 18, 2025 |
| Feb 28, 2025 | ALGS Aligos Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +140,103 | $0.00 | $0 | 140,103 | Mar 4, 2025 |
| Oct 25, 2023 | ALGS Aligos Therapeutics, Inc. | AGrant or award Common Stock | +610,277 | $0.76 | $462k | 1,847,575 | Oct 27, 2023 |
| Oct 25, 2023 | ALGS Aligos Therapeutics, Inc. | AGrant or award Warrants (Right to Buy)derivative | +305,138 | $0.13 | $38k | 305,138 | Oct 27, 2023 |
Questions about Lawrence Blatt
Answered from the filings on this page, as of the latest one.
Is Lawrence Blatt buying or selling?
Lawrence Blatt has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lawrence Blatt's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lawrence Blatt has 0.
Where does Lawrence Blatt file Form 4?
Lawrence Blatt has filed Form 4 at ALGS (Aligos Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.